OTCA14 ”Robot-assisted surgery in thoracic and visceral indications”.” Final Assessment Now Available
We are pleased to announce publication of the collaborative assessment OTCA14 “Robot-assisted surgery for thoracic and visceral surgery”. This is the assessment of the relative effectiveness and safety of robot-assisted surgery for 13 different procedures within the thoracic and visceral surgery area. The assessment is based on evidence from RCTs or –in the absence of […]
Open Call for Patient Input – Joint Assessment on a medicinal product for secondary progressive MS.
EUnetHTA recently started a new Joint Assessment on a medicinal product for secondary progressive MS. To find out about participation, please read more here. Input submissions will be received through till EOB, April 28th.
PTJA04 – “Sotagliflozin is indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy” is now available
This is the assessment of the relative effectiveness of ‘Sotagliflozin is indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy.’ Below is the documentation provided […]
The Collaborative Assessment, OTCA12, on “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs)” is now available.
The Collaborative Assessment, OTCA12, on “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs)” is now available. We are pleased to announce that the collaborative rapid assessment on “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute […]
OTCA16 Bioresorbable Stents for the Treatment of Cardiovascular Indications (coronary artery disease) Final Assessment Now Available.
We are pleased to announce that the collaborative rapid assessment, OTCA16, on “BIORESORBABLE STENTS FOR THE TREATMENT OF CARDIOVASCULAR INDICATIONS (CORONARY ARTERY DISEASE)” is now available. The health technology assessed is a device for percutaneous coronary intervention (PCI). The objective of this assessment was to evaluate the relative effectiveness and safety of this technology in […]
EUnetHTA prioritises topics for Joint Assessments
EUnetHTA publishes the EUnetHTA Prioritisation List (EPL) Find the EPL HERE The EPL expresses the identified significant interest of national HTA bodies in relation to individual compounds as presented in the list. By pro-actively selecting those topics in direct collaboration with national bodies, EUnetHTA strives to increase implementation of Joint Assessments qualitatively and quantitatively at […]
Materials now available from 1st EUnetHTA Workshop on HTA and MDR/IVDR (from 29th May 2018, Vienna) and 2nd Workshop Announced (28 May, 2019, Vienna)
We are happy to announce that the documentation of the 1st EUnetHTA Workshop on HTA and MDR/IVDR (from 29th May 2018, Vienna) is now available. Please note that the 2nd EUnetHTA Workshop will take place on TUE 28th May 2019 in Vienna. For further information please contact EUnetHTA_MedDevice_Event@hta.lbg.ac.at [pdf-embedder url=”https://www.eunethta.eu/wp-content/uploads/2018/07/Workshop1_Documentation_05.07.2018.pdf”]
OTCA12 “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs)” Final Project Plan Now Available
This is the final project plan of the assessment on C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs) and the comments provided by external experts during scoping. OTCA12_Final-project-plan.pdf OTCA12_Draft-project-plan_collated-comments-from-external-experts_fact_check_manufacturers.pdf
OTCA09 “High-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer” is now available
We are pleased to announce publication of the collaborative assessment OTCA09 “High-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer”. This is the assessment of the relative effectiveness of high-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer. The purpose of the assessment is to evaluate the relative effectiveness and safety […]
1st EUnetHTA Workshop on Health Technology Assessment (HTA) and Medical Device Regulation (MDR)/Invitro Diagnostics Regulation (IVDR)
The 1st EUnetHTA Workshop on HTA and MDR/IVDR Regulation will take place on May 29th, (08:45- 17:30) 2018 in Vienna, Austria. Registration is by invitation only. For additional information, please contact: EUnetHTA_MedDevice_Event@hta.lbg.ac.at
